ArticleIn vivo (Athens, Greece)

Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice.

Pengzhen Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.